Paroxetine HCl Hemihydrate (CAS 110429-35-1) — formula C19H20FNO3, molecular weight 329.4; category organic chemicals.
| CAS Number | 110429-35-1 |
|---|---|
| Molecular Formula | C19H20FNO3 |
| Molecular Weight | 329.4 |
| Melting Point | 120-138 |
| Boiling Point | 451.7±45.0 |
| LogP | 2.53 |
| Applications | Uses: THERAPEUTIC CATEGORY (VETERINARY): In treatment of canine and feline behavioral disorders, MEDICATION, Antidepressive Agents, Second-Generation, Serotonin Uptake Inhibitors, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 18200, Use (kg) in France (2004): 5515, Consumption (g per capita, approx.) in Germany (2009): 0.0122, Consumption (g per capita) in the USA (2002): 0.0645, Consumption (g per capita) in France (2004): 0.0913, Excretion rate: 0.03, Calculated removal (%): 97, Labeled indications include: major depressive disorder (MDD), panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders, impulse control disorders, vasomotor symptoms of menopause, obsessive-compulsive disorder (OCD) in children, and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle, which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause., Use Classification: Pharmaceuticals, Methods of Manufacturing: Grignard reaction of arecoline with 4-fluorophenylmagnesium bromide affords a cis-, trans mixture of methyl 4-(4-fluorophenyl)-N-methyl-nipecotate, which is hydrolyzed, converted into the acid chloride and esterified with (-)-menthol. The distilled methyl ester can be resolved via its hydrobromide salts to afford the (-)-trans form which upon reduction with LiAlH4 gives the desired (-)- trans alcohol. Conversion into the chloro compound with thionyl chloride and reaction with the sodium salt of 3, 4-methylenedioxyphenol in refluxing methanol for 16 hr leads to the N-methyl derivative of ..., paroxetine, . N-demethylation is achieved by reaction with phenyl- or ethyl chloroformate and hydrolysis of the urethane with KOH., Preparation: J. A. Christensen, R. F. Squires, German patent 2404113, eidem, United States of America patent 3912743, United States of America patent 4007196 (1974, 1975, 1977 all to Ferrosan)., Formulations, Preparations: Table: Paroxetine Hydrochloride Preparations [Table#6793], Table: Paroxetine Mesylate Preparations [Table#6794], Brisdelle is available as 7.5 mg pink capsules printed with black edible ink with "NOVEN" and "7.5 mg" on the capsule. Each capsule contains 9.69 mg paroxetine mesylate equivalent to 7.5 mg paroxetine base. |
| Category | Organic Chemicals |
Documented applications: Uses: THERAPEUTIC CATEGORY (VETERINARY): In treatment of canine and feline behavioral disorders, MEDICATION, Antidepressive Agents, Second-Generation, Serotonin Uptake Inhibitors, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 18200, Use (kg) in France (2004): 5515, Consumption (g per capita, approx.) in Germany (2009): 0.0122, Consumption (g per capita) in the USA (2002): 0.0645, Consumption (g per capita) in France (2004): 0.0913, Excretion rate: 0.03, Calculated removal (%): 97, Labeled indications include: major depressive disorder (MDD), panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders, impulse control disorders, vasomotor symptoms of menopause, obsessive-compulsive disorder (OCD) in children, and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle, which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause., Use Classification: Pharmaceuticals, Methods of Manufacturing: Grignard reaction of arecoline with 4-fluorophenylmagnesium bromide affords a cis-, trans mixture of methyl 4-(4-fluorophenyl)-N-methyl-nipecotate, which is hydrolyzed, converted into the acid chloride and esterified with (-)-menthol. The distilled methyl ester can be resolved via its hydrobromide salts to afford the (-)-trans form which upon reduction with LiAlH4 gives the desired (-)- trans alcohol. Conversion into the chloro compound with thionyl chloride and reaction with the sodium salt of 3, 4-methylenedioxyphenol in refluxing methanol for 16 hr leads to the N-methyl derivative of ..., paroxetine, . N-demethylation is achieved by reaction with phenyl- or ethyl chloroformate and hydrolysis of the urethane with KOH., Preparation: J. A. Christensen, R. F. Squires, German patent 2404113, eidem, United States of America patent 3912743, United States of America patent 4007196 (1974, 1975, 1977 all to Ferrosan)., Formulations, Preparations: Table: Paroxetine Hydrochloride Preparations [Table#6793], Table: Paroxetine Mesylate Preparations [Table#6794], Brisdelle is available as 7.5 mg pink capsules printed with black edible ink with "NOVEN" and "7.5 mg" on the capsule. Each capsule contains 9.69 mg paroxetine mesylate equivalent to 7.5 mg paroxetine base..
Paroxetine HCl Hemihydrate is a carbon-based organic compound with CAS registry number 110429-35-1 and molecular formula C19H20FNO3 (molecular weight 329.4), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 110429-35-1
Its molecular formula C19H20FNO3 comprises 19 C, 20 H, 1 F, 1 N, 3 O atoms.
Also known as: Paroxetine HCl Hemihydrate · 帕罗西汀盐酸盐半水合物
Category: organic chemicals
The CAS registry number of Paroxetine HCl Hemihydrate is 110429-35-1.
Molecular formula C19H20FNO3, molecular weight 329.4.
It is also registered under: Paroxetine HCl Hemihydrate, 帕罗西汀盐酸盐半水合物.
Recorded applications: Uses: THERAPEUTIC CATEGORY (VETERINARY): In treatment of canine and feline behavioral disorders, MEDICATION, Antidepressive Agents, Second-Generation, Serotonin Uptake Inhibitors, Use (kg, approx.) in Germany (2009): >1000, Use (kg) in USA (2002): 18200, Use (kg) in France (2004): 5515, Consumption (g per capita, approx.) in Germany (2009): 0.0122, Consumption (g per capita) in the USA (2002): 0.0645, Consumption (g per capita) in France (2004): 0.0913, Excretion rate: 0.03, Calculated removal (%): 97, Labeled indications include: major depressive disorder (MDD), panic disorder with or without agoraphobia, obsessive-compulsive disorder (OCD), social anxiety disorder (social phobia), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders, impulse control disorders, vasomotor symptoms of menopause, obsessive-compulsive disorder (OCD) in children, and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle, which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause., Use Classification: Pharmaceuticals, Methods of Manufacturing: Grignard reaction of arecoline with 4-fluorophenylmagnesium bromide affords a cis-, trans mixture of methyl 4-(4-fluorophenyl)-N-methyl-nipecotate, which is hydrolyzed, converted into the acid chloride and esterified with (-)-menthol. The distilled methyl ester can be resolved via its hydrobromide salts to afford the (-)-trans form which upon reduction with LiAlH4 gives the desired (-)- trans alcohol. Conversion into the chloro compound with thionyl chloride and reaction with the sodium salt of 3, 4-methylenedioxyphenol in refluxing methanol for 16 hr leads to the N-methyl derivative of ..., paroxetine, . N-demethylation is achieved by reaction with phenyl- or ethyl chloroformate and hydrolysis of the urethane with KOH., Preparation: J. A. Christensen, R. F. Squires, German patent 2404113, eidem, United States of America patent 3912743, United States of America patent 4007196 (1974, 1975, 1977 all to Ferrosan)., Formulations, Preparations: Table: Paroxetine Hydrochloride Preparations [Table#6793], Table: Paroxetine Mesylate Preparations [Table#6794], Brisdelle is available as 7.5 mg pink capsules printed with black edible ink with "NOVEN" and "7.5 mg" on the capsule. Each capsule contains 9.69 mg paroxetine mesylate equivalent to 7.5 mg paroxetine base..
Category: Organic Chemicals.
Independent reference data for Paroxetine HCl Hemihydrate (CAS 110429-35-1), compiled from public chemistry databases.
| CAS Registry Number | 110429-35-1 |
|---|---|
| PubChem CID | 43815 |
| Molecular formula | C19H20FNO3 |
| IUPAC name | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine |
| UNII (FDA) | 41VRH5220H |
| Molecular Weight | 329.4 |
|---|---|
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 329.14272166 |
| Monoisotopic Mass | 329.14272166 |
| Topological Polar Surface Area | 39.7 |
| Heavy Atom Count | 24 |
| Boiling Point | 451.7±45.0 |
|---|---|
| Melting Point | 120-138 |
| Melting Point | 129 - 131 °C |
| Solubility | 5.4 |
| Solubility | In water, 1,131 mg/L at 25 °C |
| Solubility | 8.53e-03 g/L |
| LogP | 2.53 |
| LogP | log Kow = 1.23 |
| LogP | 3.6 |
| LogP | 4.07 |
paroxetine; 61869-08-7; Frosinor; Motivan; Casbol; PaxPar; Paroxetina; Paroxetinum; (-)-Paroxetine; Aropax; Besitram; BRL 29060; BRL-29060; Arketis; Daparox; Parogen
| GHS notification summary | 16.7% (1 / 6) |
|---|
| GHS notification summary | 16.7% (1 / 6) |
|---|---|
| Reported hazard statements | H302 (66.7%), H360 (50%), H361 (16.7%), H400 (16.7%), H410 (50%), H315, H319, H335 |
This chemical does not meet GHS hazard criteria for 16.7% (1 of 6) of reports.
H302 (66.7%): Harmful if swallowed [Warning Acute toxicity, oral]
Paroxetine HCl Hemihydrate · CAS 110429-35-1 · C19H20FNO3. UNII 41VRH5220H. Boiling Point: 451.7±45.0; Melting Point: 120-138; Melting Point: 129 - 131 °C.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 帕罗西汀盐酸盐半水合物